Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

209
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
209
Probiotics01:22

Probiotics

296
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
296
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

1.7K
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.7K
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

233
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
233
Development of Human Microbiota01:30

Development of Human Microbiota

61
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dental disease among adults with and without HIV in the MACS/WIHS Combined Cohort Study (MWCCS).

BMC oral health·2026
Same author

Upper airway microbiome interacts with GSDMB and ORMDL3 asthma risk SNPs to influence early-life wheeze risk.

The Journal of allergy and clinical immunology·2026
Same author

Financial, housing, food, and healthcare insecurities and their independent and joint associations with depressive symptoms and stress in a U.S. cohort of adults with and without HIV.

Social science & medicine (1982)·2026
Same author

Carbohydrate Metabolism Differs in Infants by Asthma-risk Status and is Associated with the Functional Potential of <i>Bacteroides cellulosilyticus</i>.

bioRxiv : the preprint server for biology·2026
Same author

Association between objectively measured physical activity and maternal stool microbiota during pregnancy: results from a preliminary investigation.

Frontiers in cellular and infection microbiology·2026
Same author

Nasal steroids, irrigation, oral antibiotics, and subgroup targeting for effective management of acute sinusitis (NOSES): Protocol for a comparative effectiveness randomized controlled trial.

PloS one·2026

Related Experiment Video

Updated: Apr 30, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.7K

Fecal microbial therapy: promises and pitfalls.

Daniel Merenstein1, Najwa El-Nachef, Susan V Lynch

  • 1*Department of Family Medicine, Georgetown University Medical Center, Washington, DC †Division of Gastroenterology, Department of Medicine, University of California, San Francisco.

Journal of Pediatric Gastroenterology and Nutrition
|May 7, 2014
PubMed
Summary

Fecal microbial transplants (FMT) show high efficacy for recurrent C. difficile infection and are being explored for other diseases. This review covers the gut microbiome, FMT studies, and considerations for patient treatment.

More Related Videos

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

26.7K
Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.6K

Related Experiment Videos

Last Updated: Apr 30, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.7K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

26.7K
Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.6K

Area of Science:

  • Gastroenterology and Microbiology
  • Human Disease Research

Background:

  • The gastrointestinal microbiome plays a crucial role in human health.
  • Alterations in the gut microbiome are linked to a growing number of diverse human diseases.

Purpose of the Study:

  • To discuss the gut microbiome and its relation to human diseases.
  • To review current and ongoing studies on Fecal Microbial Transplant (FMT) as a therapeutic strategy.
  • To consider regulatory aspects and patient factors for FMT implementation.

Main Methods:

  • Literature review of published studies on FMT.
  • Analysis of ongoing clinical trials involving FMT.
  • Discussion of regulatory frameworks and clinical considerations for FMT.

Main Results:

  • Fecal Microbial Transplant (FMT) demonstrates high efficacy in treating recurrent Clostridium difficile infection.
  • FMT is being investigated for a wider range of human diseases linked to microbiome dysbiosis.

Conclusions:

  • FMT is a promising therapeutic option for specific microbiome-related disorders.
  • Further research and careful patient selection are essential for expanding FMT applications.
  • Regulatory oversight is critical for the safe and effective use of FMT.